Anti-CD22 (clone IRO30) SynExpress C-G-NF-B CD4+ T Cells

CAT#: ITS-1124-CR13
Clone: IRO30
Host: Humanized
Cell Source: Synthetic CD4+ T cells
Species Reactivity: Human
Connector Fragments: CMV-GFP-NF-κB-BamHI
Carrier Type: Retrovirus
Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO30). We employs the Retrovirus (CMV-GFP-NF-κB-BamHI) vector components and the SynExpress system of the coding regions Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO30
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
NF-κB
Insertion Sites
BamHI
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
Retrovirus
Transformation Accuracy
0.88
Cell Culture
Suspension Culture
Target
CD22
Alternative Names
CD22; SIGLEC-2; SIGLEC2; CD22 molecule
Gene ID
P16871(Human)
UniProt ID
933(Human)
Format
Lyophilized/Liquid
Shipping
All cell products are transported using dry ice, or specialized refrigerated containers to ensure that their temperature remains within an appropriate range. For cell products that are particularly sensitive to temperature, transportation must be carried out in liquid nitrogen tanks to ensure the quality and viability of the products.
Handling Advice
Handle cells in a sterile environment to prevent contamination. Use aseptic techniques when transferring to new media or containers. Follow biosafety regulations for disposing of cell waste.
Storage
Keep cell products in the designated temperature range (usually liquid nitrogen or -80°C) to maintain viability.
For Research Use Only | Not For Clinical Use
Online Inquiry